An active pharmaceutical ingredient (API) is any substance in a pharmaceutical product that is biologically active. That means the specific molecular entity is capable of achieving a defined biological effect on the target. These ingredients need to meet very strict limits; chemical and optical purity are considered to be the most important ones. A continuous-flow synthetic methodology which utilizes a continuously flowing stream of reactive fluids can be easily combined with photochemistry, which works with the chemical effects of light. These methods can be useful tools to meet these strict limits. Both of these methods are unique and powerful tools for the preparation of natural products or active pharmaceutical ingredients and their precursors with high structural complexity under mild conditions. This review shows some main directions in the field of active pharmaceutical ingredients' preparation using continuous-flow chemistry and photochemistry with numerous examples of industry and laboratory-scale applications.

Institute of Environmental Technology CEET VŠB Technical University of Ostrava 708 00 Ostrava Czech Republic

TEVA Czech Industries s r o 747 70 Opava Czech Republic

Zobrazit více v PubMed

Booker-Milburn K.I., Noel T. Flow Photochemistry. ChemPhotoChem. 2018;2:830.

Elgue S., Aillet T., Loubiere K., Conté A., Dechy-Cabaret O., Prat L., Horn C.R., Lobet O., Vallon S. Flow photochemistry: A meso-scale reactor for industrial applications. Chim. Oggi. 2015;33:58–62.

Wegner J., Ceylan S., Kirschning A. Ten key issues in modern flow chemistry. Chem. Commun. 2011;47:4583–4592. doi: 10.1039/c0cc05060a. PubMed DOI

Beeler A.B. Introduction: Photochemistry in organic synthesis. Chem. Rev. 2016;116:9629–9630. PubMed

Urge L., Alcazar J., Huck L., Dormán G. Recent advances of microfluidics technologies in the field of medicinal chemistry. Annu. Rep. Med. Chem. 2017;50:87–147.

Wegner J., Ceylan S., Kirschning A. Flow Chemistry—A Key Enabling Technology for (Multistep) Organic synthesis. Adv. Synth. Catal. 2012;354:17–57.

Hartman R.L., McCullen J.P., Jensen K.F. Deciding whether to go with the flow: Evaluating the merits of flow reactors for synthesis. Angew. Chem. Int. Ed. 2011;50:7502–7519. PubMed

Gutmann B., Cantillo D., Kappe O.C. Continuous-Flow Technology—A Tool for the Safe Manufacturing of Active Pharmaceutical Ingredients. Angew. Chem. Int. Ed. 2015;54:6688–6728. doi: 10.1002/anie.201409318. PubMed DOI

Rehm T.H. Reactor Technology Concepts for Flow Photochemistry. ChemPhotoChem. 2020;4:235–254. doi: 10.1002/cptc.201900247. DOI

Fitzpatrick D.E., Battilocchio C., Ley S.V. Enabling Technologies for the Future of Chemical Synthesis. ACS Cent. Sci. 2016;2:131–138. PubMed PMC

Porta R., Benaglia M., Coccia F., Rossi S., Puglisi A. Enantioselective Organocatalysis in Microreactors: Continuous Flow Synthesis of a (S)-Pregabalin Precursor and (S)-Warfarin. Symmetry. 2015;3:1395–1409.

Sambiagio C., Noël T. Flow Photochemistry: Shine Some Light. Trends Chem. 2020;2:92–106. doi: 10.1016/j.trechm.2019.09.003. DOI

Thomson C.G., Lee A.-L., Vilela F. Heterogeneous photocatalysis in flow chemical reactors. Beilstein J. Org. Chem. 2020;16:1495–1549. doi: 10.3762/bjoc.16.125. PubMed DOI PMC

Politano F., Oksdath-Mansila G. Light on the horizon: Current research and future perspective of flow-photochemistry. Org. Process Res. Dev. 2018;22:1045–1062. doi: 10.1021/acs.oprd.8b00213. DOI

Baumann M., Baxendale R. The synthesis of active pharmaceutical ingredients (APIs) using continuous flow chemistry. Beilstein J. Org. Chem. 2015;11:1194–1219. doi: 10.3762/bjoc.11.134. PubMed DOI PMC

Snead D.R., Jamison T.F. A three-minute synthesis and purification of Ibuprofen: Pushing the limits of continuous-flow processing. Angew. Chem. Int. Ed. Engl. 2015;54:983–987. PubMed

Baumann M., Moody T.S., Smyth M., Wharry S. A Perspective on Continuous Flow Chemistry in the Pharmaceutical. Org. Process Res. Dev. 2020;24:1802–1813. doi: 10.1021/acs.oprd.9b00524. DOI

Malet-Sanz L., Susanne F. Continuous Flow Synthesis. A Pharma Perspective. J. Med. Chem. 2012;55:4062–4098. doi: 10.1021/jm2006029. PubMed DOI

Bogdan A.R., Organ M.G. Flow Chemistry for the Synthesis of Heterocycles. Springer International Publishing; Cham, Switzerland: 2018. Flow chemistry as a drug discovery tool: A medicinal chemistry perspective; pp. 319–341.

Bogdan A.R., Dombrowski A.W. Emerging trends in flow chemistry and applications to the pharmaceutical industry. J. Med. Chem. 2019;62:6422–6468. doi: 10.1021/acs.jmedchem.8b01760. PubMed DOI

Bogdan A.R., Poe S.L., Kubis D.C., Broadwater S.J., McQuade D.T. The continuous-flow synthesis of Ibuprofen. Angew. Chem. Int. Ed. 2009;48:8547–8550. doi: 10.1002/anie.200903055. PubMed DOI

Porta R., Benaglia M., Puglisi A. Flow chemistry: Recent developments in the Synthesis of Pharmaceutical products. Org. Process Res. Dev. 2016;20:2–25.

Suttie J.W. Warfarin and vitamin K. Clin. Cardiol. 1990;13:VI–16–VI–18. PubMed

Atropine. [(accessed on 18 October 2022)]. Available online: https://go.drugbank.com/drugs/DB00572.

Sztejnberg A. Albert Ladenburg (1842-1911) – The Distinguished German Chemist and Historian of Chemistry of the Second Half of the XIX Century (To the 110th Anniversary of His Death) Substantia. 2021;5:153–164. doi: 10.36253/Substantia-1231. DOI

Grynkiewicz G., Gadzikowska M. Tropane alkaloid as medicinally useful natural products and their synthetic derivatives as new drugs. Pharmacol. Rep. 2008;60:439–463. PubMed

Dai C., Snead D.R., Zhang P., Jamison T.F. Continuous-Flow Synthesis and Purification of Atropine with Sequential In-Line Separations of Structurally Similar Impurities. J. Flow. Chem. 2015;5:133–138. doi: 10.1556/1846.2015.00013. DOI

Bédard A.C., Longstreet A.R., Britton J., Wang Y., Moriguchi H., Hicklin R.W., Green W.H., Jamison T.F. Minimizing E-factor in the continuous flow synthesis of Diazepam and Atropine. Bioorgan. Med. Chem. 2017;25:6233–6241. PubMed

Diab S., Gerogiorgis D.I. Process modeling, simulation and technoeconomic optimisation for continuous pharmaceutical manufacturing of (S)-warfarin. Comput. Aided Chem. Eng. 2018;43:1643–1648.

Yang Y., Cui Y., Sang K., Dong Y., Ni Z., Ma S., Hu H. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature. 2018;554:317–322. PubMed

Stevens C.L. Aminoketones and Methods for Their Production. 3254124. U.S. Patent. 1966 May 31;

Chmabers S.A., DeSousa J.M., Huseman E.D., Townsend S.D. The DARK side of total synthesis: Strategies and tactics in psychoactive drug production. ACS Chem. Neurosci. 2018;10:2307–2330. PubMed PMC

Kassin V.H., Gérardy R., Toupy T., Collin D., Salvadeo E., Toussaint F., van Hecke K., Monbaliu J.C. Expedient preparation of active pharmaceutical ingredient ketamine under sustainable continuous flow conditions. Green Chem. 2019;21:2952–2966. doi: 10.1039/C9GC00336C. DOI

Morodo R., Bianchi P., Monbaliu J.-C.M. Continuous flow organophosphorus chemistry. Eur. J. Org. Chem. 2020;33:5235–5278. doi: 10.1002/ejoc.202001149. DOI

Peng B., Lloyd P., Schran H. Clinical pharmacokinetics of Imatinib. Clin. Pharmacokinet. 2005;44:879–894. doi: 10.2165/00003088-200544090-00001. PubMed DOI

Hopkin M.D., Baxendale I.R., Ley S.V. A flow-based synthesis of Imatinib: The API of Gleevec. Chem. Commun. 2010;46:2450–2452. doi: 10.1039/c001550d. PubMed DOI

Fu W.C., Jamison T.F. Modular continuos flow synthesis of Imatinib and analogues. Org. Lett. 2019;21:6112–6116. PubMed

Bloemendal V.R.L.J., Janssen M.A., van Hest J.C.M., Rutjes F.P.J.T. Continuous one-flow multi-step synthesis of active pharmaceutical ingredients. React. Chem. Eng. 2020;5:1186–1197. doi: 10.1039/D0RE00087F. DOI

Rufinamide. [(accessed on 21 March 2021)]; Available online: https://medlineplus.gov/druginfo/meds/a609001.html.

Sorbera L., Leeson P., Rabasseda X., Castaner J. Rufinamide. Antiepileptic, treatment of neurogenic pain. Drugs Future. 2000;25:1145–1149. doi: 10.1358/dof.2000.025.11.599595. DOI

Mudd W.H., Stevens E.P. An afficient synthesis of Rufinamide, an antiepileptic drug. Tetrahedron Lett. 2010;51:3229–3231. doi: 10.1016/j.tetlet.2010.04.060. DOI

Ott D., Borukhova S., Hessel V. Life cycle assessment of multi-step rufinamide synthesis—From isolated reactions in batch to continuous microreactor networks. Green Chem. 2016;18:1096–1116.

Borukhova S., Noel T., Metten B., de Vos E., Hessel V. Solvent- and Catalyst-Free Huisgen Cycloaddition to Rufinamide in Flow with a Greener, Less Expensive Dipolarophile. ChemSusChem. 2013;6:2220–2225. doi: 10.1002/cssc.201300684. PubMed DOI

Zhang P., Russell M.G., Jamison T.F. Continuous flow synthesis of Rufinamide. Org. Process Res. Dev. 2014;18:1567–1570. doi: 10.1021/op500166n. DOI

Bogdan A.R., Sach N.W. The Use of Copper Flow Reactor Technology for the Continuous Synthesis of 1,4-Disubstituted 1,2,3-Triazoles. Adv. Synth. Catal. 2009;351:849–854. doi: 10.1002/adsc.200800758. DOI

Chatterjee S., Guidi M., Seeberger P., Gilmore K. Automated radial synthesis of organic molecules. Nature. 2020;579:379–384. doi: 10.1038/s41586-020-2083-5. PubMed DOI

Magano J. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza. Chem. Rev. 2009;109:4398–4438. doi: 10.1021/cr800449m. PubMed DOI

Mukaiyama T., Ishikawa H., Koshino H., Hayashi Y. One-pot synthesis of (-)-Oseltamivir and mechanistic insights into the organocatalyzed Michael reaction. Chem.-Eur. J. 2013;19:17789–17800. PubMed

Ogasawara S., Hayashi Y. Multistep Continuous-flow synthesis of (-)-Oseltamivir. Synthesis. 2017;49:424–428.

Clemett D., Markham A. Prolonged-release mesalazine: A review of its therapeutic potential in ulcerative colitis and Crohn’s disease. Drugs. 2000;4:815–827. doi: 10.2165/00003495-200059040-00007. PubMed DOI

Perrault W.R. The Synthesis of N-Aryl-5(S)-aminomethyl-2-oxazolidinone Antibacterials and Derivatives in One Step from Aryl Carbamates. Org. Process Res. Dev. 2003;7:533–546. doi: 10.1021/op034028h. DOI

Russell M.G., Jamison T.F. Seven-step continuous flow synthesis of Linezolid without intermediate purification. Angew. Chem. Int. Ed. 2019;58:7678–7681. PubMed

Taylor J.W., Armstrong T., Kim A.H., Venere M., Acquaye A., Schrag D., Wen P.Y. The Lomustine crisis: Awareness and impact of the 1500% price hike. Neuro-Oncol. 2019;21:1–3. PubMed PMC

Loftus P. Cancer drug price rises 1400% with no generic to challenge it. Wall Str. J. 2017;12:26.

Jaman Z., Sobreira T.J., Mufti A., Ferreira C.R., Cooks R.G., Thompson D.H. Rapid On-Demand Synthesis of Lomustine under Continuous Flow Conditions. Org. Process Res. Dev. 2019;23:334–341. doi: 10.1021/acs.oprd.8b00387. DOI

MacDonald R.L., Olsen R.W. GABAA receptor channels. Annu. Rev. Neurosci. 1994;17:569–602. PubMed

Sommer N., LöSchmann P.A., Northoff G.H., Weller M., Steinbrecher A., Steinbach J.P., Lichtenfels R., Meyermann R., Riethmüller A., Fontana A., et al. The antidepressant Rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat. Med. 1995;1:244–248. doi: 10.1038/nm0395-244. PubMed DOI

Tsubogo T., Oyamada H., Kobayashi S. Multistep continuous-flow synthesis of (R)- and (S)-Rolipram using heterogeneous catalyst. Nature. 2015;520:329–332. doi: 10.1038/nature14343. PubMed DOI

Yoo W.J., Ishitani H., Saito Y., Laroche B., Kobayashi S. Reworking organic synthesis for the modern age: Synthetic strategies based on continuous flow addition and condensation reactions with heterogeneous catalyst. J. Org. Chem. 2020;85:5132–5145. doi: 10.1021/acs.joc.9b03416. PubMed DOI

Kernan W.N., Viscoli C.M., Brass L.M., Broderick J.P., Brott T., Feldmann E., Morgenstern L.B., Wilterdink J.L., Horwitz R.I. Phenylpropanolamine and the risk of hemorrhagic stroke. N. Engl. J. Med. 2000;343:1826–1832. doi: 10.1056/NEJM200012213432501. PubMed DOI

Rossi S., Porta R., Brenna D., Puglisi A., Benaglia M. Stereoselective Catalytic Synthesis of Active Pharmaceutical. Angew. Chem. Int. Ed. 2017;56:4290–4294. PubMed

Baumann M., Baxendale I.R. Continuous Photochemistry: The flow synthesis of Ibuprofen via a Photo-Favorskii rearrangement. React. Chem. Eng. 2016;1:147–150.

Karioti A., Bilia A.R. Hypericins as Potential Leads for New Therapeutics. Int. J. Mol. Sci. 2010;2:562–594. doi: 10.3390/ijms11020562. PubMed DOI PMC

Joniova J., Rebic M., Strejckova A., Huntosova V., Stanicova J., Jancura D., Miskovsky P., Bano G. Formation of large Hypericin aggregates in giant unilamellar vesicles – experiments and modeling. Biophys J. 2017;112:966–975. PubMed PMC

Do M.H., Kim S.Y. Hypericin, a Naphthodianthrone derivative, prevents methylglyoxal-induced human endothelial cell dysfunction. Biomol. Ther. 2017;25:158–164. PubMed PMC

Huntosova V., Novotova M., Nichtova Z., Balogová L., Maslankova M., Petrovajova D., Stroffekova K. Assessing light-independent effects of hypericin on cell viability, ultrastructure and metabolism in human glioma and endothelial cells. Toxicol. Vitro. 2017;40:184–195. PubMed

Brockmann H. Carotinoide von P. Karrer und E. Jucker, Lehrbücher und Monographien aud dem Gebiete der exakten Wissenschaften, Chemische Reihe Band III. Verlag Birkhäuser, Basel 1948. 388 S. 28 Bilder. Preis broschiert 39.–Fr., geb. 43.– Fr. Angew. Chem. 1949;61:389. doi: 10.1002/ange.19490610611. DOI

Brockmann H., Eggers H. Partial synthese von photo-hypericin und Hypericin aus Penicilliopsin. Chem. Ber. 1958;91:81–100. doi: 10.1002/cber.19580910117. DOI

Aigner S., Falk H. A microwave-assisted synthesis of phenanthroperylene quinones as exemplified with hypericin. Monatsh. Chem. 2008;139:991–993.

Huang L.F., Wang Z.H., Chen S.L. Hypericin: Chemical synthesis and biosynthesis. Chin. J. Nat. Med. 2014;12:81–88. doi: 10.1016/S1875-5364(14)60014-5. PubMed DOI

Steglich W., Arnold R. Synthesis of Hypericin and Related meso-Naphthodianthrones by Alkaline Dimerization of Hydroxyanthraquinones. Angew. Chem. Int. Ed. Engl. 1973;12:79. doi: 10.1002/anie.197300791. PubMed DOI

Mazur Y., Bock H., Lavie D. Preparation of Hypericin. 5,120,412A. US Patent. 1992 June 9;

Falk H., Schoppel G. On the synthesis of hypericin by oxidative trimethylemodin anthrone and emodin anthrone dimerization: Isohypericin. Monatsh. Chem. 1992;123:931–938.

Gruszecka-Kowalik E., Zalkow L.H. An improved synthesis of Hypericin and related compounds. Org. Prep. Proced. Int. 2000;32:57–61. doi: 10.1080/00304940009356746. DOI

Goncalves R.S., Rabello B.R., César G.B., Periera P.C.S., Ribeiro M.A.S., Meurer E.C., Hioka N., Nakamura C.V., Bruschi M.L., Caetano W. An efficient multigram synthesis of Hypericin improved by a low powered LED based photoreactor. Org. Process Res. Dev. 2017;21:2025–2031.

Frankowski K.I., Setola V., Evans J.M., Neuenswander B., Roth B.L., Aubé J. Synthesis and receptor profiling of Stemona alkaloid analogues reveal a potent class of sigma ligands. PNAS. 2011;108:6727–6732. doi: 10.1073/pnas.1016558108. PubMed DOI PMC

Hook B.D.A., Dohle W., Hirst P.R., Pickworth M., Berry M.B., Booker-Milburn K.I. A practical flow reactor for continuous organic photochemistry. J. Org. Chem. 2005;70:7558–7564. doi: 10.1021/jo050705p. PubMed DOI

Lainchbury M.D., Medley M.I., Taylor P.M., Hirst P., Dohle W., Booker-Milburn K.I. A Protecting Group Free Synthesis of (±)-Neostenine via the [5+2] Photocycloaddition of Maleimides. J. Org. Chem. 2008;73:6497–6505. doi: 10.1021/jo801108h. PubMed DOI

Cambié D., Bottecchia C., Straathof N.J., Hessel V., Noel T. Applications of continuous-flow photochemistry in organic synthesis, material science, and water treatment. Chem. Rev. 2016;116:10276–10341. PubMed

Tuchinda P., Munyoo B., Pohmakotr M., Thinapong P., Sophasan S., Santisuk T., Reutrakul V. Cytotoxic Styryl-Lactones from the Leaves and Twigs of Polyalthia crassa. J. Nat. Prod. 2006;12:1728–1733. PubMed

Popsavin V., Sreco B., Benedecovic G., Francuz J., Popsavin M., Kojic V., Bogdanovic G. Design, synthesis and antiproliferative activity of styryl lactones related to (+)-goniofufurone. Eur. J. Med. Chem. 2010;45:2876–2883. doi: 10.1016/j.ejmech.2010.03.010. PubMed DOI

Michael R., Ng S., Booker-Milburn K.I. Short flow-photochemistry enabled synthesis of the cytotoxic lactone (+)-Goniofufurone. Org. Lett. 2016;18:968–971. PubMed

Dembitsky V., Shkrob I., Hanus L.O. Ascaridole and related peroxides from the genus Chenopodium. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czechoslov. Repub. 2008;2:209–215. PubMed

Pare P.W., Zajicek J., Ferracini V.L., Melo I.S. Antifungal terpenoids from Chenopodium ambrosioides. Biochem. Syst. Ecol. 1993;21:649–653.

Efferth T., Olbrich A., Sauerbrey A., Ross D.D., Gebhart E., Neugebauer M. Activity of Ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cells. Anticancer Res. 2002;22C:4221–4224. PubMed

Wootton R.C.R., Fortt R., de Mello A.J. A Microfabricated Nanoreactor for Safe, Continuous Generation and Use of Singlet Oxygen. Org. Process Res. Dev. 2002;6:187–189. doi: 10.1021/op0155155. DOI

Knowles J.P., Elliott L.D., Booker-Milburn K.I. Flow photochemistry: Old light through new windows. Beilstein J. Org. Chem. 2012;8:2025–2052. doi: 10.3762/bjoc.8.229. PubMed DOI PMC

Bundred N., Howell A. Fulvestrant (Faslodex[trademark]): Current status in the therapy of breast cancer. Expert Rev. Anticancer Ther. 2002;2:151. doi: 10.1586/14737140.2.2.151. PubMed DOI

Rosso C., Williams J.D., Filippini G., Prato M., Kappe C.O. Visible-light mediated Iodoperfluoroalkylation of alkenes in flow and its application to the synthesis of a key Fulvestrant intermediate. Org. Lett. 2019;21:5341–5345. doi: 10.1021/acs.orglett.9b01992. PubMed DOI

Brazier E.J., Hogan P.J., Leung C.W., O´Kearney-McMullan A., Norton A.K., Powell L., Robinson G.E., Williams E.G. Fulvestrant: From the Laboratory to Commercial-Scale Manufacture. Org. Process. Res. Dev. 2010;14:544. doi: 10.1021/op900315j. DOI

Qian L.Y., Yang L., Tian X. Podophylloxin: Current perspectives. Curr. Bioact. Compd. 2007;3:37–66. doi: 10.2174/157340707780126499. DOI

Lisiecki K., Czarnocki Z. Flow photochemistry as a tool for the total synthesis of (+)-Epigalcatin. Org. Lett. 2018;20:605–607. PubMed

Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411–415. PubMed

Sakurawi K., Yasuda F., Tozyo T., Nakamura M., Sato T., Kikuchi J., Terui Y., Ikenishi Y., Iwata T., Takahashi K., et al. Endothelin receptor antagonist triterpenoid, Myriceric acid A, Isolated from Myrica cerifera, nad structure activity relationship of its derivatives. Chem. Pharm. Bull. 1996;44:343–351. doi: 10.1248/cpb.44.343. PubMed DOI

Sugimoto A., Sumino Y., Takagi M., Fukuyama T., Ryu I. The Barton reaction using a microreactor and Black light. Continuous flow synthesis of a key steroid intermediate for an Endothelin receptor antagonist. Tetrahedron Lett. 2006;47:6197–6200.

Sugimoto A., Fukuyama T., Sumino Y., Takagi M., Ryu I. Microflow photo-radical reaction using a compact light source: Application to the Barton reaction leading to a key intermediate for myriceric acid A. Tetrahedron. 2009;65:1593–1598.

Aweeka F.T., German P.I. Clinical pharmacology of Artemisinin-based combination therapies. Clin. Pharmacokinet. 2008;47:91–102. doi: 10.2165/00003088-200847020-00002. PubMed DOI

Krieger J., Smeilus T., Kaiser M., Seo E.-J., Efferth T., Giannis A. Total synthesis and biological investigation of (-)-Artemisinin: The antimalarial activity of Artemisinin is not stereospecific. Angew. Chem. Int. Ed. 2018;57:8293–8296. PubMed

Lévesque F., Seeberger P.H. Continuous-flow synthesis of the anti-malaria drug artemisinin. Angew. Chem. Int. Ed. 2012;51:1706–1709. doi: 10.1002/anie.201107446. PubMed DOI

Callaway E., Cyranoski D. Anti-parasite drugs sweep Nobel prize in medicine 2015. Nature. 2015;526:174–175. PubMed

Peplow M. Sanofi Launches Malaria Drug Production. [(accessed on 4 April 2021)]. Available online: https://www.chemistryworld.com/news/sanofi-launches-malaria-drug-production/6068.article.

WebMD. [(accessed on 4 April 2021)]. Available online: https://www.webmd.com/drugs/2/drug-6152/cholecalciferol-vitamin-d3-oral/details.

Fuse S., Tanabe N., Yoshida M., Yoshida H., Doi T., Takahashi T. Continuous-flow synthesis of vitamin D3. Chem. Commun. 2009;46:8722–8724. doi: 10.1039/c0cc02239j. PubMed DOI

Dauben W.G., Phillips R.B. Wavelenght-Controlled production of previtamin D3. J. Am. Chem. Soc. 1982;104:355–356.

Davidson M.H., Robinson J.G. Lipid/lowering effects of statins> a comparative review. Expert Opin. Pharmacother. 2006;13:1701–1704. doi: 10.1517/14656566.7.13.1701. PubMed DOI

Šterk D., Jukič M., Časar Z. Application of Flow Photo-chemical Bromination in the synthesis of 5-Bromomethylpyrimidine precursors of Rosuvastatin: Improvement of productivity and product purity. Org. Process Res. Dev. 2013;1:145–151.

Machado L., Spengler G., Evaristo M., Handzlik J., Molnár J., Viveiros M., Kiec-Konowicz K., Amaral L. Biological activity of twenty-three Hydantoin derivatives on Intrinsic efflux pump system of Salmonella enterica serovar Enteritidis NCTC 13349. In Vivo. 2011;5:25, 769–772. PubMed

Vukelic S., Koksch B., Seeberger P.H., Gilmore K. A sustainable, semi-continuous flow synthesis of Hydantoins. Chem.-Eur. J. 2016;22:13451–13454. doi: 10.1002/chem.201602609. PubMed DOI

Diekema D.J., Jones R.N. Oxazolidinone antibiotics. Lancet. 2001;358:1975–1982. PubMed

Gravestock M.B. Recent developments in the discovery of novel oxazolidinone antibacterials. Curr. Opin. Drug Discov. Devel. 2005;8:469–477. PubMed

Davies S.G., Fletcher A.M., Frost A.B., Roberts P.M., Thompson J.E. Trading N and O. Part 2: Exploiting aziridinium intermediates for the synthesis of β-hydroxy-α-amino acids. Tetrahedron. 2014;70:5849–5862.

Slama S., Besbes R. Stereoselective synthesis of erythro-β-chloroamines and their conversion into functionalized trans-oxazolidin-2-ones. Tetrahedron. 2014;70:4732–4737. doi: 10.1016/j.tet.2014.05.063. DOI

Crich D., Banerjee A. Expedient Synthesis of threo-β-Hydroxy-α-amino Acid Derivatives:  Phenylalanine, Tyrosine, Histidine, and Tryptophan. J. Org. Chem. 2006;71:7106–7109. PubMed PMC

Chen Y., de Frutos O., Mateos C., Rincon J.A., Cantillo D., Kappe C.O. Continuous flow photochemical benzylic bromination of a key intermediate in the synthesis of a 2-Oxazolidinone. ChemPhotoChem. 2018;2:906–912. doi: 10.1002/cptc.201800114. DOI

Bacon C.W., D´Orso I. CDK9: A signaling hub for transcriptional control. Transcription. 2019;2:57–75. doi: 10.1080/21541264.2018.1523668. PubMed DOI PMC

Cassandri M., Fioravanti R., Pomella S., Valente S., Rotili D., del Baldo G., de Angelis B., Rota R., Mai A. CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas. Front. Pharmacol. 2020;11:1230. doi: 10.3389/fphar.2020.01230. PubMed DOI PMC

Herbrik F., Sanz M., Puglisi A., Rossi S., Benaglia M. Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient. Chem. Eur. J. 2022;28:e202200164. doi: 10.1002/chem.202200164. PubMed DOI PMC